Prediction of neonatal chronic lung disease by serum syndecan-4
Project/Area Number |
26461642
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Embryonic/Neonatal medicine
|
Research Institution | Keio University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
松崎 陽平 慶應義塾大学, 医学部(信濃町), 助教 (60327583)
谷野 功典 福島県立医科大学, 医学部, 准教授 (10443863)
|
Project Period (FY) |
2014-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Keywords | syndecan-4 / 慢性肺疾患 / 絨毛膜羊膜炎 / 臍帯血 / 胎児血 |
Outline of Final Research Achievements |
We made a hypothesis that syndecan-4 elevated in chronic lung disease infant after chorioanmionatis and that the difference in expression of syndecan-4 in early time after delivery could reflect degree of chronic lung disease in preterm infants. First, we measured syndecan-4 in term infants for reference value. We tried the measurement of syndecan-4 in preterm infants, however,umbilical cord blood or residual serum for this study were too insufficient to analyze even after one year extension of the research.
|
Report
(5 results)
Research Products
(8 results)